Technical University Munich-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2022

  1. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial

    The Lancet Haematology, Vol. 9, Núm. 8, pp. e594-e604

2005

  1. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients

    Thrombosis and Haemostasis, Vol. 94, Núm. 4, pp. 750-759

2004

  1. Compliance with recommended prophylaxis for venous thromboembolism: Improving the use and rate of uptake of clinical practice guidelines

    Journal of Thrombosis and Haemostasis, Vol. 2, Núm. 2, pp. 221-227

1999

  1. Workshop II: The future of prolonged thromboprophylaxis

    Blood Coagulation and Fibrinolysis